LANETTE

Lannett Company is a pharmaceutical firm primarily engaged in the development, manufacturing, and distribution of generic versions of brand-name drug products. Founded in 1942, the company offers a diverse portfolio of medications across multiple therapeutic categories, including cardiovascular, gastrointestinal, and pain management. Lannett has recently expanded its focus into more complex generics and biosimilars, notably through a partnership to develop biosimilar insulin products. Following a successful financial restructuring in 2023, the company operates as a private entity, continuing its mission to provide high-quality, affordable medicines to the U.S. healthcare market. The company maintains significant manufacturing and distribution operations within the United States.